Understanding how T cells help prevent respiratory virus spread
Exploring the role of T cells in protection from respiratory virus transmission
This study is looking at how certain immune cells called T cells help protect us from respiratory viruses by stopping infections from spreading, and it's aimed at finding new ways to boost our immunity against these viruses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11106890 on NIH RePORTER |
What this research studies
This research investigates the role of T cells in providing immunity against respiratory viruses, focusing on how these immune cells can prevent the transmission of infections. By using animal models, the study aims to identify specific T cell populations that can recognize and eliminate infected cells before the virus spreads. The research will explore the interactions between these T cells and other cells in the respiratory tract to understand how they can effectively inhibit viral propagation. This work is crucial for developing new strategies to enhance immunity against respiratory viruses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at high risk for respiratory viral infections, such as those with compromised immune systems or underlying health conditions.
Not a fit: Patients who are not at risk for respiratory viral infections or those who have already developed strong immunity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines or therapies that enhance immune protection against respiratory viruses, reducing the risk of transmission and severe disease.
How similar studies have performed: Previous research has shown that T cells play a critical role in controlling viral infections, suggesting that this approach has the potential for success.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Kohlmeier, Jacob E — Emory University
- Study coordinator: Kohlmeier, Jacob E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.